The ex-dividend date for Amgen (Nasdaq:AMGN) is Monday, May 14, 2012. Owners of shares as of market close today will be eligible for a dividend of 36 cents per share. At a price of $70.02 as of 9:30 a.m., the dividend yield is 2.1%.
NEW YORK ( TheStreet) -- The ex-dividend date for Amgen (Nasdaq: AMGN) is Monday, May 14, 2012. Owners of shares as of market close today will be eligible for a dividend of 36 cents per share. At a price of $70.02 as of 9:30 a.m. ET, the dividend yield is 2.1%. The average volume for Amgen has been 4.1 million shares per day over the past 30 days. Amgen has a market cap of $54.14 billion and is part of the health care sector and drugs industry. Shares are up 9.2% year to date as of the close of trading on Thursday. Amgen Inc., a biotechnology medicines company, discovers, develops, manufactures, and markets human therapeutics based on advances in cellular and molecular biology for grievous illnesses primarily in the United States, Europe, and Canada. The company has a P/E ratio of 16.1, equal to the average drugs industry P/E ratio and below the S&P 500 P/E ratio of 17.7.
TheStreet Ratings rates Amgen as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, notable return on equity, attractive valuation levels and increase in net income. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. You can view the full Amgen Ratings Report. See our dividend calendar or top-yielding stocks list.